14 studies found for:    "hereditary multiple exostoses" OR "Exostoses, Multiple Hereditary" OR "Osteochondromatosis" OR "Osteochondroma"
Show Display Options
Rank Status Study
1 Suspended The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses
Condition: Exostoses, Multiple Hereditary
2 Terminated Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC
Condition: Exostoses, Multiple Hereditary
3 Suspended Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project
Condition: Exostoses, Multiple Hereditary
4 Completed A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002 EXT 1)
Condition: Rheumatoid Arthritis
Interventions: Biological: MK-8808 500 mg/m^2;   Biological: Rituximab 500 mg/m^2;   Drug: Methotrexate;   Biological: MabThera (rituximab) 500 mg/m^2;   Biological: Rituxan (rituximab) 500 mg/m^2;   Biological: MK-8808 1000 mg
5 Completed A Dose-Range Finding Study in Patient With Type 2 Diabetes (MK-3102-006 EXT1[AM3])
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MK-3102;   Drug: Placebo;   Drug: pioglitazone;   Drug: metformin
6 Completed
Has Results
Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))
Condition: Multiple Myeloma
Interventions: Drug: vorinostat;   Drug: bortezomib
7 Completed
Has Results
Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)
Condition: Lymphoma
Intervention: Drug: vorinostat
8 Completed A Study of the Efficacy and Safety of MK-4618 in Patients With Overactive Bladder (OAB) (MK-4618-008 AM3 EXT1[AM2])
Condition: Urinary Bladder, Overactive
Interventions: Drug: MK-4618 low-dose;   Drug: MK-4618 mid-low dose;   Drug: MK-4618 mid-high dose;   Drug: tolterodine ER;   Drug: Placebo for MK-4618;   Drug: Placebo for tolterodine ER;   Drug: MK-4618 high dose
9 Completed Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001 EXT1)(COMPLETED)
Condition: Pneumococcal Vaccines
Interventions: Biological: Adults-Adjuvanted V114;   Biological: Adults-Prevnar™;   Biological: Toddlers-Adjuvanted V114;   Biological: Toddlers-Non-adjuvanted V114;   Biological: Toddlers-Prevnar™
10 Completed
Has Results
Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)
Conditions: Leukemia, Myelocytic, Acute Myelodysplastic Syndromes;   Myelodysplastic Syndromes
Interventions: Drug: vorinostat;   Drug: decitabine
11 Completed
Has Results
An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))
Condition: Proteinuria
Interventions: Drug: Losartan Potassium;   Other: Comparator: Placebo (Losartan);   Drug: Comparator: amlodipine besylate;   Other: Comparator: Placebo (amlodipine besylate);   Other: Placebo (Losartan);   Drug: Enalapril Maleate
12 Terminated
Has Results
Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: MK-0941;   Drug: Comparator: Placebo;   Biological: Lantus;   Drug: Metformin
13 Completed Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (0683-014 AM5, EXT1)
Conditions: Mesothelioma;   Lung Cancer
Interventions: Drug: vorinostat;   Drug: Placebo
14 Completed Chronic Insertional Achilles Tendonitis Treated With or Without Flexor Hallucis Longus Tendon Transfer
Condition: Chronic Insertional Achilles Tendonitis
Interventions: Procedure: Achilles decompression & debridement;   Procedure: Achilles decompression and debridement with FHL transfer

Indicates status has not been verified in more than two years